期刊文献+

紫杉醇联合肿瘤坏死因子α对腺样囊性癌细胞的抑制作用 被引量:1

Study of apoptosis of salivary adenoid cystic carcinoma induced by TNF-α and paclitaxel in vitro
原文传递
导出
摘要 目的:探讨人肿瘤坏死因子α(TNF-α)联合紫杉醇对人腺样囊性癌细胞系SACC-83的抑制增殖作用及与细胞凋亡的关系,为化疗与生物治疗联合应用治疗腺样囊性癌提供实验依据。方法:将人腺样囊性癌细胞系SACC-83和对照组原代培养鼠肺成纤维细胞根据不同药物浓度分为9组,药物作用72 h。3H-TDR法检测细胞增殖抑制率;流式细胞术检测细胞凋亡率及细胞周期改变;透射电镜观察凋亡细胞形态变化。结果:联合用药组的细胞增殖抑制率显著高于单独用药组(P<0.05)。L929细胞各组的细胞增殖抑制率显著低于SACC-83细胞(P<0.05)。结论:TNF-α联合紫杉醇对SACC-83细胞增殖的抑制作用以及诱导凋亡具有协同作用。 Objective: To explore the apoptosis mechanism of salivary adenoid cystic carcinoma cells (SACC-83) induced by recombinant human tumor necrosis factor or(rhTNF-α) and paclitaxel. Methods: The SACC-83 cells and primary culture of L929 cells were divided into nine groups of different medicine concentration and exposed for 72h. The inhibition ratio of cell proliferation was detected with 3H-TDR. The percentage of apoptotic cells and cell cycle distribution were detected by the flow cytometer. The cell morphological change of apoptosis was observed. Results: The inhibition ratio of cell proliferation in as- sociated drugs group was significant higher than that of either single drug group ( P 〈 0.05 ). The inhibition ratio of cell prolifera- tion of every group of L929 cell was significant lower than that of SACC-83 cell (P 〈 0.05). Conclusion: TNF-αassociated with paclitaxel is synergetic to inhibit SACC-83 cells and induce apoptosis.
出处 《军医进修学院学报》 CAS 北大核心 2008年第4期265-267,共3页 Academic Journal of Pla Postgraduate Medical School
关键词 紫杉醇 肿瘤坏死因子Α 涎腺肿瘤 细胞凋亡 paclitaxel TNFα salibary gland neoplasms apoptosis
  • 相关文献

参考文献5

  • 1殷海珊,王洁,董福生,顾洪涛,李荷香,焦建平.重组人肿瘤坏死因子与维甲酸诱导涎腺腺样囊性癌细胞凋亡的实验研究[J].现代口腔医学杂志,2002,16(6):485-488. 被引量:4
  • 2林李嵩,林国础,陈万涛,郭伟,姚明.紫杉醇对腺样囊性癌抗瘤作用及对细胞周期的影响[J].中华口腔医学杂志,2001,36(6). 被引量:9
  • 3Boise LH, Gonzalez Gareia M, Postema CE, et al. bel-x, a bel-2 related gene that functions as a dominant regulator of apoptotie cell death[J] Cell, 1993, 74(4) :597-608.
  • 4Srivastava RK, Srivastava AR, Korsmeyer S J, et al. Involvement of microtubules in the regulation of bcl-2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase [ J ]. Mol Cell Biol, 1998, 18(6) :3509-3517.
  • 5Seong J; Milross CG, Hunter NR, et al. Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alpha [ J ]. Anticancer-Drugs, 1997, 8 ( 1 ) :80-87.

二级参考文献2

共引文献10

同被引文献15

  • 1徐德生,贾强,郑立高,张志远,李彦和,张宜培.眶内及眶颅沟通性肿瘤的伽玛刀放射治疗[J].立体定向和功能性神经外科杂志,2005,18(5):296-298. 被引量:13
  • 2郑刚,郭传瑸,俞光岩,黄敏娴,彭歆,黄俊.腺样囊性癌患者生存预测模型的建立[J].中华口腔医学杂志,2006,41(6):350-353. 被引量:13
  • 3Fordiee J, Kershaw C, EI-Naggar A, et al. Adenoid cystic carcinoma of the head and neck; predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg, 1999, 125: 149- 152.
  • 4Ben Simon GJ, Schwarcz RM, Douglas R, et al. Orbital exenteration: one size does not fit all. Am J Ophthalmol, 2005, 139.11-17.
  • 5Gurney TA, Eisele DW, Weinberg V, et al. Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation. Laryngoscope, 2005,115:1278- 1282.
  • 6Khafif A, Anavi Y, Haviv J, et al. Adenoid cystic carcinoma of the salivary glands : a 20-year review with long-term follow-up. Ear Nose Throat J, 2005, 84:662,664-667.
  • 7Kawaguchi O, Kunieda E, Fujii H, et al. Adenoid cystic carcinoma with hyperostosis after stereotactic radiosurgery. Radiat Med, 2004, 22:198-200.
  • 8Meldrum ML, Tse DT, Benedetto P. Neoadjuvant intracarotid chemotherapy for treatment of advanced adenocystic carcinoma of the lacrimal gland. Arch Ophthalmol, 1998,116:315-321.
  • 9Sun CX, He RG, Cheung LK. The biological behaviour of human adenoid cystic carcinoma cells transduced with interleukin-2-gene. Int J Oral Maxillofac Surg, 2002,31:650-656.
  • 10Guan X, Qiu W, He R, et al. Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung: an experimental study. Inter J Oral Maxi Surg, 1997, 26: 116-119.

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部